The 2013 Site Solutions Summit features Pearl Pathways’ own Diana Caldwell. She will be involved in the roundtable discussions as a panelist and moderator for topics such as: Investigator Insider: What your site needs to know about your next potential investigator;...
Pharmalive.com’s Ed Silverman reports that in another attempt to stop the European Medicines Agency (EMA) from continuing with their new policy for trial data disclosure, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has openly...
On September 10, 2013, the Tufts Center for the Study of Drug Development released a report concerning the leading causes of failures in drug development. Based on a study of products that entered clinical development from 2000 through 2009, the study found that Phase...
The Pearl IRB has undergone changes in design and functionality as well as content. You will quickly notice the new, updated design of the homepage, as well as several other content changes. Summary of changes: New homepage design Easy to use icons on homepage with...
Pearl Pathways will be joining more than 500 clinical executives making the commitment to research site success at the 2013 Site Solutions Summit. Hosted by the Society for Clinical Research Sites, the Summit provides 3 days of networking and takeaways designed to...
